Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen

Infection and Immunity

Volumn 69, Issue 3, 2001, Pages 1381-1388

  McCormick, J K ^a   Pragman, A A ^a   Stolpa, J C ^a   Leung, D Y M ^a   Schlievert, P M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYSTINE; NUCLEOTIDE; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CLONING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RABBIT; SPLEEN CELL; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; CLONING, MOLECULAR; CROSS REACTIONS; EVOLUTION, MOLECULAR; EXOTOXINS; FEVER; MOLECULAR SEQUENCE DATA; PHYLOGENY; PYROGENS; RABBITS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCUS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS;

EID: 0035118067     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.3.1381-1388.2001     Document Type: Article

References (65)

1. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes
2. Mitogenic factors from group G streptococci associated with scarlet fever and streptococcal toxic shock syndrome
3. Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins
4. A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots
5. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses
6. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases
7. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s
8. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children
9. Severe invasive group A streptococcal infections in Ontario, Canada: 1997-1991
10. Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994
11. Bacteriophage association of streptococcal pyrogenic exotoxin type C
12. Nucleotide sequence of streptococcal pyrogenic exotoxin type C
13. Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor
14. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome
15. Toxic shock-like syndrome caused by non-group A beta-hemolytic streptococci
16. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study
17. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989
18. Mitogenic factor secreted by Streptococcus pyogenes is a heat-stable nuclease requiring His122 for activity
19. Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B
20. Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A
21. A physical map of the group A streptococcal pyrogenic exotoxin bacteriophage T12 genome
22. Transfer of group A streptococcal pyrogenic exotoxin production to nontoxigenic strains of lysogenic conversion
23. Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production
24. Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: An integrin-binding cysteine protease
25. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes
26. Molecular population genetic evidence of horizontal spread of two alleles of the pyrogenic exotoxin C gene (speC) among pathogenic clones of Streptococcus pyogenes
27. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin
28. Toxic strep syndrome associated with group C Streptococcus
29. Bacterial pyrogenic exotoxins as superantigens
30. Toxic shock-like syndrome caused by group G Streptococcus
31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
32. Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins
33. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production
34. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis
35. The structural basis of T cell activation by superantigens
36. The staphylococcal enterotoxins and their relatives
37. Toxins and superantigens of group A streptococci
38. Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome
39. Bacteriophage T12 of Streptococcus pyogenes integrates into the gene encoding a serine tRNA
40. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with amino-terminal homology to staphylococcal enterotoxins B and C
41. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: Clonal diversity and pyrogenic exotoxin expression
42. A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints
43. Toxic shock syndrome due to group C streptococci. A case report
44. Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates
45. Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection
46. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF)
47. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1
48. Identification and characterization of novel superantigens from Streptococcus pyogenes
49. The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation
50. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome
51. Streptococcal superantigens: Streptococcal toxic shock syndrome
52. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome
53. Group A streptococcal pyrogenic exotoxin: Pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock
54. Streptococcal toxic shock syndrome associated with necrotizing fasciitis
55. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A
56. Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis
57. Structural basis for HLA-DQ binding by the streptococcal superantigen SSA
58. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome
59. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
60. Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein
61. Signal sequences. The limits of variation
62. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project
63. Nucleotide sequence of the type A streptococcal cxotoxin (erythrogenic toxin) gene from Streptococcus pyogenes bacteriophage T12
64. A new type of mitogenic factor produced by Streptococcus pyogenes
65. The role of temperate bacteriophage in the production of erythrogenic toxin by group A streptococci